Syracuse, New York
Facts and Figures
- Since 1943, Bristol-Myers Squibb employees in Syracuse, New York, have been developing and manufacturing new medicines that help patients prevail over serious diseases. From the early days of penicillin to the current era of protein therapeutics, Bristol-Myers Squibb has maintained a strong commitment to the Syracuse community through employment, philanthropic endeavors and environmental stewardship.
- Several critical functions are located at this 90-acre site in East Syracuse, New York including:
- Development of biologics manufacturing processes (shared with employees located at our Hopewell, New Jersey facility)
- Manufacturing of biologics medicines for use in clinical trials
- Manufacturing of biologics medicines for commercial use
- Employees also have responsibility for authoring sections of drug applications for regulatory agencies around the world as well as providing technical transfer expertise for internal and third party manufacturing sites.
- Consistent with the corporate strategy to become a BioPharma leader, the company is transforming its site in East Syracuse to better support its current work in biologics. The site is transforming its physical appearance from a traditional industrial look to a greener biotechnology campus. The work completed by 2013 included demolition of 50 obsolete and idle buildings and structures associated with discontinued antibiotic manufacturing processes.
- This facilities transformation project is consistent and aligned with the corporate commitment to environmental sustainability, as the removal of outdated buildings and idle equipment will result in a significant reduction in energy consumption and ultimately the site’s overall carbon footprint.
- The company is partnering with the State University of New York, College of Environmental Science and Forestry landscape architecture students to provide design ideas to the company for consideration as part of its facilities transformation project. As part of their landscape architecture studio, the students are benefiting from a 'real world' project that will enable them to build their portfolio, while the company will receive creative design ideas which complement the company's philosophy on sustainability.
Community and Social Progress
- The Syracuse site supports more than 50 not-for-profit organizations in Central New York. Priority areas for contributions include: hospitals and health organizations, science education initiatives and neighborhood programs. Additionally, employees participate in a variety of community activities such as: participating in not-for-profit fundraising walks, days of caring projects, and serving on boards of directors.
- The company donated $1 million to the Golisano Children’s Hospital which offers state-of-art care for pediatric patients in a 17-county region.
- The company also launched an integrated business and science curricula at East Syracuse Minoa High School called RxeSEARCH: An Educational Journey. This program is a comprehensive educational program that teaches students about the drug development process. The program is novel in its approach to integrated teaching and learning of biology, chemistry, math, social studies and language arts. It strives to educate today's youth about the risks and rewards of developing new medicines with the goal of creating informed consumers of healthcare. RxeSEARCH: An Educational Journey prepares students for careers in science, technology, engineering and math.
- In 2010, the Syracuse site achieved a milestone of three million hours worked without a lost time injury. This is equivalent to a family of four going more than 85 years without an injury or illness that would cause one of them to miss a day of school or work. The manufacturing portion of the site also reached a milestone in 2010 by working more than a year without an accident requiring more than basic first-aid treatment.
- Also in 2010, the Syracuse site received the President’s Safety Award in recognition of our outstanding safety performance within Bristol-Myers Squibb.
- The Syracuse site remains focused on continuous improvement of its safety program and continues to enhance its safety culture.
- Bristol-Myers Squibb Syracuse manufacturing is focused on large molecule, biologic-based medicines. These processes are water-based, produce lower emissions and generate less hazardous waste than typical small molecule, solvent-based processes.
- Since 2008, the site has reduced its hazardous waste generation by greater than 75%, its process chemical emissions by 45% and its combustion-based emissions by 33%.
- The site has made significant progress toward the company’s Sustainability 2015 Goals for water and energy usage.
Facility Contact Information
Main site phone number